Close

TUBA1B

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YJ412 Anti-TUBA1B (3G3) h(41BB-CD3ζ) CAR, pCDCAR1 Human 3G3 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ413 Anti-TUBA1B (3H2) h(41BB-CD3ζ) CAR, pCDCAR1 Human 3H2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ414 Anti-TUBA1B (4D1) h(41BB-CD3ζ) CAR, pCDCAR1 Human 4D1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ415 Anti-TUBA1B (17H11.F10) h(41BB-CD3ζ) CAR, pCDCAR1 Human, Mouse, Rat, Chicken 17H11.F10 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ912 Anti-TUBA1B (3G3) h(CD28-CD3ζ) CAR, pCDCAR1 Human 3G3 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ913 Anti-TUBA1B (3H2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 3H2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ914 Anti-TUBA1B (4D1) h(CD28-CD3ζ) CAR, pCDCAR1 Human 4D1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ915 Anti-TUBA1B (17H11.F10) h(CD28-CD3ζ) CAR, pCDCAR1 Human, Mouse, Rat, Chicken 17H11.F10 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.